查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
连接酶市场 - 2017-2027 年全球行业规模、份额、趋势、机会和预测，按产品、来源、按应用、最终用户、公司和地区细分
市场调查报告书
商品编码
1303140

连接酶市场 - 2017-2027 年全球行业规模、份额、趋势、机会和预测，按产品、来源、按应用、最终用户、公司和地区细分

Ligase Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By Source, By Application, By End User, By company and By Region
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球连接酶市场在 2023-2027 年预测期内将出现令人印象深刻的增长。主要因素包括传染病、遗传病和慢性病患病率的上升以及研发活动的增加正在推动市场的增长。连接酶是通过连接两个分子形成新的化学键来催化反应的酶。连接酶在分子诊断方法中发挥着至关重要的作用，因为它确保了靶向治疗的安全有效的应用。支持市场增长的其他因素包括疾病治疗需求的增加、研发投资的增加、研发的不断增长、诊断和製药公司的扩张、先进技术的采用以及世界人口的增长。此外，不断增加的战略增长（例如合併、合作和收购）正在加强市场的增长。例如，2021 年，BLIRT SA 扩大了其位于科技园和格但斯克科学中心的实验室设施。新实验室致力于扩大关键酶的生产规模并改进生产工艺。

疾病治疗中对连接酶的需求不断增长

全球慢性病、传染病和遗传性疾病发病率的激增正在推动市场的增长。患有这些疾病之一的患者数量不断增加是一个促成因素。因此，对更好的治疗以提供更好的患者护理的需求正在推动市场的增长。由于不健康的选择、生活方式的改变、快餐的消费等，不仅老年人口，年轻一代也容易患上这些疾病。因此，加强了市场的增长。例如，根据世界卫生组织的数据，每年有1790万人死于心血管疾病，其次是930万人死于癌症，410万人死于慢性呼吸道疾病，最后是200万人死于糖尿病（包括肾病） 。同样，根据世界卫生组织的估计，每1000人中就有10人患有遗传病。

增加研发和大量投资推动市场增长

全球范围内使用连接酶作为治疗干预措施的研发 (R&D) 活动的兴起正在推动市场的增长。由于研究活动的增加，它们被用于多种目的，如突变检测、克隆、药物靶点等，从而反过来推动了市场的增长。例如，2022年3月，一项名为“SUMO E3 Ligases in Signaling Pathway of Cancer Cells”的研究表明，小泛素样修饰剂（SUMO）化是一种可逆的翻译后修饰，在多种细胞信号通路中发挥着至关重要的作用。细胞生理学的各个方面，包括细胞週期调节、蛋白质运输和 DNA 损伤修復，这些对于细胞稳态至关重要。此外，酶分子诊断研发活动投资的增加正在促进市场的增长。 2021年，默克在达姆施塔特全球总部投资了2.825亿美元。该公司正致力于为其医疗保健业务部门建设一个新的转化科学中心和一个新的学习中心。

可用的定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球连接酶市场的影响

第 5 章：客户之声

第 6 章：全球连接酶市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 副产品（快速连接酶、T4 DNA 连接酶、大肠桿菌 DNA 连接酶、T4 RNA 连接酶、其他）
    • 按来源（古细菌、大肠桿菌、嗜热栖热菌、其他）
    • 按应用（连接酶炼式反应、连接酶检测反应、下一代测序、分子克隆等）
    • 按最终用户（生物技术和製药公司、学术和研究机构、其他）
    • 按地区
    • 按公司划分 (2021)
  • 市场地图

第 7 章：北美连接酶市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品分类
    • 按来源
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 8 章：欧洲连接酶市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品分类
    • 按来源
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 9 章：亚太连接酶市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品分类
    • 按来源
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 10 章：南美连接酶市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品分类
    • 按来源
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章：中东和非洲连接酶市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品分类
    • 按来源
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非连接酶
    • 沙特阿拉伯连接酶
    • 阿联酋连接酶

第 12 章：市场动态

  • 司机
  • 挑战

第 13 章：市场趋势与发展

第14章：竞争格局

  • Bio-Rad 实验室有限公司
  • 安捷伦科技公司
  • 法德西斯公司
  • F.霍夫曼-拉罗氏股份公司
  • 默克公司
  • 普洛麦格公司
  • 凯杰公司
  • ArcticZymes 技术公司
  • 赛默飞世尔科技公司
  • 宝生物株式会社

第 15 章：战略建议

简介目录
Product Code: 13055

The global ligase market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the rising prevalence of infectious, genetic, and chronic diseases and the increase in R&D activities are impelling the growth of the market. Ligases are enzymes that catalyze the reaction by joining two molecules to form a new chemical bond. Ligase has a crucial role in the molecular diagnostics method, as it makes sure the safe and effective application of targeted therapeutics. The other factors supporting the market's growth are, increasing demand for disease treatment, increasing investments in R&D, growing research & development, expansion of diagnostics and pharmaceutical companies, adoption of advanced technology, and rising world population. Also, the increasing strategic growth, such as mergers, collaborations, and acquisitions, is strengthening the growth of the market. For instance, in 2021, BLIRT S.A. enlarged its laboratory facility at Technology Park and Gdansk Science. The new laboratory is involved in growing its production scale for key enzymes and improving production processes.

Growing Need for Ligases in Disease Treatment

The surge in incidences of chronic diseases, infectious diseases, and genetic disorders across the globe is bolstering the growth of the market. The rising number of patients suffering from one of these diseases is a contributing factor. Thus, the need for better treatment to provide better patient care is fueling the growth of the market. Not only the geriatric population but the younger generation are prone to these diseases due to unhealthy choices, lifestyle changes, consumption of fast foods, and others. Thus, strengthening the growth of the market. For instance, according to WHO, every year, 17.9 million people die from cardiovascular diseases, followed by 9.3 million deaths by cancer, 4.1 million deaths from chronic respiratory diseases, and lastly, 2.0 million deaths caused by diabetes, including kidney disease. Similarly, according to the estimation of WHO, 10 out of every 1000 people are affected by genetic diseases.

Increasing R&D and Heavy Investments Fuels the Market Growth

The rise in research and development (R&D) activities across the globe to use ligase as a therapeutic intervention is propelling the growth of the market. Owing to the increase in research activities, they are used for various purposes such as mutation detection, cloning, drug targets, and others, thus, in turn, impelling the growth of the market. For instance, in March 2022, a research study named "The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells" stated that small ubiquitin-like modifier (SUMO)ylation is a reversible post-translational modification that plays a vital role in several aspects of cell physiology, including cell cycle regulation, protein trafficking, and DNA damage repair, which are essential for cell homeostasis. Moreover, the rising investments in R&D activities for enzyme-based molecular diagnostics are facilitating the growth of the market. In 2021, Merck invested $282.5 million at its global headquarters in Darmstadt. The company is focusing on building a new translational science center for its healthcare business sector and a new learning center.

Market Segmentation

The global ligase market is segmented into product, source, application, end user, and company. Based on product, the market is segmented into quick ligase, T4 DNA ligase, E.Coli DNA ligase, T4 RNA ligase, and others. Based on the source, the market is segmented into Archaebacterium, escherichia coli, Thermus thermophilus, and others. Based on application, the market is segmented into ligase chain reaction, ligase detection reaction, next-generation sequencing, molecular cloning, and others. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of research and development and clinical trial programs in the country.

Market Players

Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Codexis, Inc., F. Hoffmann-La Roche AG, Merck KGaA, Promega Corporation, QIAGEN N.V., ArcticZymes Technologies ASA, Thermo Fisher Scientific, Inc., and Takara Bio Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global ligase market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Ligase Market, By Product:

  • Quick Ligase
  • T4 DNA Ligase
  • E.Coli DNA Ligase
  • T4 RNA Ligase
  • Others

Ligase Market, By Source:

  • Archaebacterium
  • Escherichia coli
  • Thermus thermophilus
  • Others

Ligase Market, By application:

  • Ligase Chain Reaction
  • Ligase Detection Reaction
  • Next-Generation Sequencing
  • Molecular Cloning
  • Others

Ligase Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Others

Ligase Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Ligase Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Ligase Market

5. Voice of Customer

6. Global Ligase Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Quick Ligase, T4 DNA Ligase, E.Coli DNA Ligase, T4 RNA Ligase, Others)
    • 6.2.2. By Source (Archaebacterium, Escherichia coli, Thermus thermophilus, Others)
    • 6.2.3. By Application (Ligase Chain Reaction, Ligase Detection Reaction, Next Generation Sequencing, Molecular Cloning, Others)
    • 6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2021)
  • 6.3. Market Map

7. North America Ligase Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Source
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Ligase Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Ligase Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Ligase Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Ligase Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Source
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Ligase Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Ligase Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Ligase Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Ligase Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Ligase Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Ligase Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Source
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Ligase Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Ligase Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Ligase Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Ligase Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Source
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Ligase Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Source
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Ligase Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Source
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ligase Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Ligase Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Ligase Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Ligase Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Source
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Ligase Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Source
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Ligase Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Source
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Ligase Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Source
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Bio-Rad Laboratories, Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Codexis, Inc.
  • 14.4. F. Hoffmann-La Roche AG
  • 14.5. Merck KGaA
  • 14.6. Promega Corporation
  • 14.7. QIAGEN N.V.
  • 14.8. ArcticZymes Technologies ASA
  • 14.9. Thermo Fisher Scientific, Inc.
  • 14.10. Takara Bio Inc.

15. Strategic Recommendations